Compugen (CGEN) EBITDA Margin Growth (1y) (2010 - 2026)
Compugen (CGEN) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1,049.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,238.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -1,651.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,002.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,091.00 |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | 4,683.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,683.00 |
| Dec 31, 2025 | 59,194.00 |
| Sep 30, 2025 | -44,364.00 |
| Jun 30, 2025 | -170,196.00 |
| Mar 31, 2025 | 3,571.00 |
| Dec 31, 2024 | -56,245.00 |
| Dec 31, 2023 | 10,080.00 |
| Dec 31, 2016 | -1.65 Mn |
| Sep 30, 2016 | -836,221.00 |
| Jun 30, 2016 | 170,503.00 |
| Mar 31, 2016 | -830,635.00 |
| Dec 31, 2015 | 827.00 |
| Sep 30, 2015 | -275,187.00 |
| Jun 30, 2015 | -294,900.00 |
| Mar 31, 2015 | -107,713.00 |
| Dec 31, 2014 | 20,597.00 |
| Sep 30, 2014 | 951.00 |
| Jun 30, 2014 | 2.13 Mn |
| Mar 31, 2014 | 229,169.00 |
| Dec 31, 2013 | 264,343.00 |